Open AccessComprehensive treatment for multicentric giant cell tumors of the pelvis and spine using apatinib: A case report and literature review
Author(s) -
Jun Li,
Wei Song,
Jun Zhou,
Yuntong Liu,
Xiaogang Sun
Publication year - 2020
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 1998-4138
pISSN - 0973-1482
DOI - 10.4103/jcrt.jcrt_892_19
Subject(s) - apatinib , medicine , denosumab , zoledronic acid , surgery , sacrum , bisphosphonate , vomiting , pelvis , chemotherapy , osteoporosis
There are no standardized treatments for giant cell tumors of the bone (GCTB) in rare locations such as the spine and pelvis or for those that are inoperable and recurrent, let alone for multicentric GCTB. This study reports a novel case of multicentric GCTB treated with a promising antiangiogenic drug, apatinib, a small-molecule tyrosine kinase inhibitor. The efficacy of apatinib in the treatment of GCTB has not been reported previously.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom